Drug Shortage Report for TEVA-TOPISONE

Last updated on 2020-02-21 History
Report ID 104362
Drug Identification Number 00804991
Brand name TEVA-TOPISONE
Common or Proper name TEVA-TOPISONE 0.05% CREAM
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) BETAMETHASONE
Strength(s) .05%
Dosage form(s) CREAM
Route of administration TOPICAL
Packaging size 15g
ATC code D07AC
ATC description CORTICOSTEROIDS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-22
Estimated end date 2020-02-29
Actual end date 2020-02-20
Shortage status Resolved
Updated date 2020-02-21
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-02-21 French Compare
v3 2020-02-21 English Compare
v2 2020-01-24 French Compare
v1 2020-01-24 English Compare